
Medical research · Cardiology and nephrology
SGLT2 inhibitors beyond glucose lowering: strength of the cardiovascular and kidney mechanisms
Asked: What mechanisms explain the cardiovascular and kidney benefits of SGLT2 inhibitors beyond glucose lowering, and how strong is the evidence for each?



